getsmart schreef op 13 maart 2015 16:36:
Goed nieuws uit het buitenland over Pharming Ruconest, verkoop is veilig gesteld in USA en het wordt zelfs beter!! lees het artikel.
Ruconest, Pharming’s HAE drug partnered with Salix, has recorded its first US sales in November 2014 and they might turn out far stronger than expected.
Despite concerns about Ruconest's future arising from Salix’s announced acquisition by Valeant, and now Endo’s counteroffer, everything seems to be going fine and Ruconest will continue to be effectively sold.
Ahead of Q1-2015 results, I believe there is significant short-term upside potential not yet taken into account.
dus eindelijk maar toch..ups ups ups te verwachten...